Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Defining HLA-II Ligand Processing and Binding Rules with Mass Spectrometry Enhances Cancer Epitope Prediction.

Abelin JG, Harjanto D, Malloy M, Suri P, Colson T, Goulding SP, Creech AL, Serrano LR, Nasir G, Nasrullah Y, McGann CD, Velez D, Ting YS, Poran A, Rothenberg DA, Chhangawala S, Rubinsteyn A, Hammerbacher J, Gaynor RB, Fritsch EF, Greshock J, Oslund RC, Barthelme D, Addona TA, Arieta CM, Rooney MS.

Immunity. 2019 Oct 15;51(4):766-779.e17. doi: 10.1016/j.immuni.2019.08.012. Epub 2019 Sep 5.

PMID:
31495665
2.

Re-excision Rate after Partial Mastectomy in Oncoplastic Breast-Conserving Surgery: A Single-Institutional Experience and Review of the Literature.

Benjamin MA, Sinnott C, Bawa S, Kaufman DI, Guarino K, Addona T.

Ann Plast Surg. 2019 Apr;82(4S Suppl 3):S170-S172. doi: 10.1097/SAP.0000000000001874.

PMID:
30855383
3.

The Role of Mass Spectrometry and Proteogenomics in the Advancement of HLA Epitope Prediction.

Creech AL, Ting YS, Goulding SP, Sauld JFK, Barthelme D, Rooney MS, Addona TA, Abelin JG.

Proteomics. 2018 Jun;18(12):e1700259. doi: 10.1002/pmic.201700259. Epub 2018 Feb 23. Review.

4.

Treatment of the Open Glenohumeral Joint with the Anterior Deltoid Muscle Flap.

Xipoleas GD, Woods D, Batac J, Addona T.

Plast Reconstr Surg Glob Open. 2016 Oct 5;4(10):e1068. eCollection 2016 Oct.

5.

Spinal reconstruction for osteomyelitis with free vascularized fibular grafts using intra-abdominal recipient vessels: A series of three cases.

Aliano KA, Agulnick M, Cohen B, Gonya G, Low C, Stavrides S, Addona T, Goncalves J, Shin D, Kilgo MS, Davenport TA.

Microsurgery. 2013 Oct;33(7):560-6. doi: 10.1002/micr.22150. Epub 2013 Sep 6.

PMID:
24014308
6.

Design, implementation and multisite evaluation of a system suitability protocol for the quantitative assessment of instrument performance in liquid chromatography-multiple reaction monitoring-MS (LC-MRM-MS).

Abbatiello SE, Mani DR, Schilling B, Maclean B, Zimmerman LJ, Feng X, Cusack MP, Sedransk N, Hall SC, Addona T, Allen S, Dodder NG, Ghosh M, Held JM, Hedrick V, Inerowicz HD, Jackson A, Keshishian H, Kim JW, Lyssand JS, Riley CP, Rudnick P, Sadowski P, Shaddox K, Smith D, Tomazela D, Wahlander A, Waldemarson S, Whitwell CA, You J, Zhang S, Kinsinger CR, Mesri M, Rodriguez H, Borchers CH, Buck C, Fisher SJ, Gibson BW, Liebler D, Maccoss M, Neubert TA, Paulovich A, Regnier F, Skates SJ, Tempst P, Wang M, Carr SA.

Mol Cell Proteomics. 2013 Sep;12(9):2623-39. doi: 10.1074/mcp.M112.027078. Epub 2013 May 20.

7.

Complete calvarial agenesis in conjunction with a Tessier 1-13 facial cleft.

Addona T, Friedman A, Post A, Weiss N, Silver L, Taub PJ.

Cleft Palate Craniofac J. 2012 Jul;49(4):484-7. doi: 10.1597/08-232.

PMID:
22839097
8.

A pipeline that integrates the discovery and verification of plasma protein biomarkers reveals candidate markers for cardiovascular disease.

Addona TA, Shi X, Keshishian H, Mani DR, Burgess M, Gillette MA, Clauser KR, Shen D, Lewis GD, Farrell LA, Fifer MA, Sabatine MS, Gerszten RE, Carr SA.

Nat Biotechnol. 2011 Jun 19;29(7):635-43. doi: 10.1038/nbt.1899.

9.

Rictor phosphorylation on the Thr-1135 site does not require mammalian target of rapamycin complex 2.

Boulbes D, Chen CH, Shaikenov T, Agarwal NK, Peterson TR, Addona TA, Keshishian H, Carr SA, Magnuson MA, Sabatini DM, Sarbassov dos D.

Mol Cancer Res. 2010 Jun;8(6):896-906. doi: 10.1158/1541-7786.MCR-09-0409. Epub 2010 May 25.

10.

Quantification of cardiovascular biomarkers in patient plasma by targeted mass spectrometry and stable isotope dilution.

Keshishian H, Addona T, Burgess M, Mani DR, Shi X, Kuhn E, Sabatine MS, Gerszten RE, Carr SA.

Mol Cell Proteomics. 2009 Oct;8(10):2339-49. doi: 10.1074/mcp.M900140-MCP200. Epub 2009 Jul 13.

11.

Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma.

Addona TA, Abbatiello SE, Schilling B, Skates SJ, Mani DR, Bunk DM, Spiegelman CH, Zimmerman LJ, Ham AJ, Keshishian H, Hall SC, Allen S, Blackman RK, Borchers CH, Buck C, Cardasis HL, Cusack MP, Dodder NG, Gibson BW, Held JM, Hiltke T, Jackson A, Johansen EB, Kinsinger CR, Li J, Mesri M, Neubert TA, Niles RK, Pulsipher TC, Ransohoff D, Rodriguez H, Rudnick PA, Smith D, Tabb DL, Tegeler TJ, Variyath AM, Vega-Montoto LJ, Wahlander A, Waldemarson S, Wang M, Whiteaker JR, Zhao L, Anderson NL, Fisher SJ, Liebler DC, Paulovich AG, Regnier FE, Tempst P, Carr SA.

Nat Biotechnol. 2009 Jul;27(7):633-41. doi: 10.1038/nbt.1546. Epub 2009 Jun 28. Erratum in: Nat Biotechnol. 2009 Sep;27(9):864.

12.

Developing multiplexed assays for troponin I and interleukin-33 in plasma by peptide immunoaffinity enrichment and targeted mass spectrometry.

Kuhn E, Addona T, Keshishian H, Burgess M, Mani DR, Lee RT, Sabatine MS, Gerszten RE, Carr SA.

Clin Chem. 2009 Jun;55(6):1108-17. doi: 10.1373/clinchem.2009.123935. Epub 2009 Apr 16.

13.

Leadership trends in plastic surgery.

Addona T, Polcino M, Silver L, Taub PJ.

Plast Reconstr Surg. 2009 Feb;123(2):750-3. doi: 10.1097/PRS.0b013e318197ed20.

PMID:
19182639
14.

Metabolite profiling of blood from individuals undergoing planned myocardial infarction reveals early markers of myocardial injury.

Lewis GD, Wei R, Liu E, Yang E, Shi X, Martinovic M, Farrell L, Asnani A, Cyrille M, Ramanathan A, Shaham O, Berriz G, Lowry PA, Palacios IF, Taşan M, Roth FP, Min J, Baumgartner C, Keshishian H, Addona T, Mootha VK, Rosenzweig A, Carr SA, Fifer MA, Sabatine MS, Gerszten RE.

J Clin Invest. 2008 Oct;118(10):3503-12. doi: 10.1172/JCI35111.

15.

Accurate inclusion mass screening: a bridge from unbiased discovery to targeted assay development for biomarker verification.

Jaffe JD, Keshishian H, Chang B, Addona TA, Gillette MA, Carr SA.

Mol Cell Proteomics. 2008 Oct;7(10):1952-62. doi: 10.1074/mcp.M800218-MCP200. Epub 2008 Jun 4.

16.

De novo peptide sequencing via manual interpretation of MS/MS spectra.

Addona T, Clauser K.

Curr Protoc Protein Sci. 2002 May;Chapter 16:Unit 16.11. doi: 10.1002/0471140864.ps1611s27.

PMID:
18429223
17.

Quantitative, multiplexed assays for low abundance proteins in plasma by targeted mass spectrometry and stable isotope dilution.

Keshishian H, Addona T, Burgess M, Kuhn E, Carr SA.

Mol Cell Proteomics. 2007 Dec;6(12):2212-29. Epub 2007 Oct 15.

18.

Regulation of IRAK-4 kinase activity via autophosphorylation within its activation loop.

Cheng H, Addona T, Keshishian H, Dahlstrand E, Lu C, Dorsch M, Li Z, Wang A, Ocain TD, Li P, Parsons TF, Jaffee B, Xu Y.

Biochem Biophys Res Commun. 2007 Jan 19;352(3):609-16. Epub 2006 Nov 21.

PMID:
17141195
19.

Safety and reliability of tattooing colorectal neoplasms prior to laparoscopic resection.

Feingold DL, Addona T, Forde KA, Arnell TD, Carter JJ, Huang EH, Whelan RL.

J Gastrointest Surg. 2004 Jul-Aug;8(5):543-6.

PMID:
15239988
20.

Selective detection of glycopeptides on ion trap mass spectrometers.

Sullivan B, Addona TA, Carr SA.

Anal Chem. 2004 Jun 1;76(11):3112-8.

PMID:
15167790
21.

A novel 110 kDa form of myosin XVIIIA (MysPDZ) is tyrosine-phosphorylated after colony-stimulating factor-1 receptor signalling.

Cross M, Csar XF, Wilson NJ, Manes G, Addona TA, Marks DC, Whitty GA, Ashman K, Hamilton JA.

Biochem J. 2004 May 15;380(Pt 1):243-53.

22.

The temporal sequence of periosteal attachment after elevation.

Boutros S, Bernard RW, Galiano RD, Addona T, Stokes B, McCarthy JG.

Plast Reconstr Surg. 2003 May;111(6):1942-7.

PMID:
12711956
23.

Apoptosis induced by cryo-injury in human colorectal cancer cells is associated with mitochondrial dysfunction.

Yang WL, Addona T, Nair DG, Qi L, Ravikumar TS.

Int J Cancer. 2003 Jan 20;103(3):360-9.

24.

Threading of a glycosylated protein loop through a protein hole: implications for combination of human chorionic gonadotropin subunits.

Xing Y, Williams C, Campbell RK, Cook S, Knoppers M, Addona T, Altarocca V, Moyle WR.

Protein Sci. 2001 Feb;10(2):226-35.

25.

Vitamin E and EDTA Improve the Efficacy of Hypothermosol-Implication of Apoptosis.

Mathew AJ, Hollister WR, Addona T, Baust JG, Van Buskirk RG.

In Vitr Mol Toxicol. 1999;12(3):163-172.

PMID:
10894766
26.
27.

Nephritogenic mAb 5-1-6 is directed at the extracellular domain of rat nephrin.

Topham PS, Kawachi H, Haydar SA, Chugh S, Addona TA, Charron KB, Holzman LB, Shia M, Shimizu F, Salant DJ.

J Clin Invest. 1999 Dec;104(11):1559-66. Erratum in: J Clin Invest 2000 Jan;105(1):125.

28.

De novo peptide sequencing via tandem mass spectrometry.

Dancík V, Addona TA, Clauser KR, Vath JE, Pevzner PA.

J Comput Biol. 1999 Fall-Winter;6(3-4):327-42.

PMID:
10582570
29.

Cloning of a yeast 8-oxoguanine DNA glycosylase reveals the existence of a base-excision DNA-repair protein superfamily.

Nash HM, Bruner SD, Schärer OD, Kawate T, Addona TA, Spooner E, Lane WS, Verdine GL.

Curr Biol. 1996 Aug 1;6(8):968-80.

Supplemental Content

Loading ...
Support Center